You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Amgen announces Q4 2022 dividend
31 October 2022 -

Amgen (NASDAQ: AMGN), a United States-based biopharmaceutical company, announced on Friday its dividend for the fourth quarter of 2022.

The company has declared dividend of USD1.94 per share.

This dividend will be paid to shareholders of record as of 17 November 2022 on 8 December 2022.

Login
Username:

Password:


Related Headlines

iECURE Raises USD 65m to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases

Enveric Biosciences Completes Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders

Grünenthal, Kyowa Kirin Ink JV Collaboration for Established Medicines Portfolio

Medicure reports quarter ended 30 September 2022 financial results

Lemonex, IVI Exchange Agree to Jointly Develop Vaccines

Perrigo Company announces USD0.26 per share dividend

Amgen announces Q4 2022 dividend

Symeres announces acquisition of Exemplify BioPharma

Eli Lilly and Company announces dividend for fourth quarter of 2022

Biocorp and Merck KGaA, Darmstadt, Germany Partner on Smart Drug Delivery

BIOCORP and Germany's Merck sign smart drug delivery agreement

Pfizer to supply up to 6 million Paxlovid treatments to Global Fund

Abbott announces quarterly common dividend

AbbVie announces quarterly cash dividend

Common and Affordable Drug Can Drastically Reduce COVID Complications, Study Shows

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2023